Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Wockhardt Ltd Capital/Financing Update 2018

Nov 2, 2018

59231_rns_2018-11-02_bd65a103-231d-416c-b93a-f7201d1566ab.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

2nd November, 2018

BSE Limited National Stock Exchange of India Limited
Corporate Relations Department Exchange Plaza
P J Towers Bandra Kurla Complex
Dalai Street Bandra (E)
Mumbai - 400 001 Mumbai - 400 051
Scrip Code: 532300 NSE Svmbol: WOCKPHARMA

Dear Sirs,

This is in continuation to our earlier communication dated 17th October, 2018 and pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

We wish to inform the Exchanges that the Board of Directors at its meeting to be held on 10th November, 2018, inter-alia, will also consider:

  • i. raising of funds through issuance of Non-Convertible Debentures/ Bonds on private placement basis. The funds, as and when raised, would be within the approved limits of the Shareholders obtained under Section 180(1)(c) of the Companies Act, 2013; and
  • ii. issuance of Preference Shares on preferential basis subject to approval of the Shareholders of the Company by way of Postal Ballot.

Kindly take the above information on record.

Thanking you,

for Wockhardt Limited

Narendra Singh Company Secretary

WOCKHARDT LIMITED • Global Headquarters: Wockhardt Towers, Bandra Kurla Complex, Mumbai-400051, India • T: 91-22 26534444 F: 91 -22-26523905 • Regd. Office: D-4 MIDC, Chikalthana, Aurangabad-431006, India »T: 91-240-6632222 • F: 91 -240-2489219 www.wockhardt.com • CIN: L24230MH1999PLC120720